Mediolanum Cardio Research
13
3
4
6
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 65/100
15.4%
2 terminated/withdrawn out of 13 trials
75.0%
-11.5% vs industry average
15%
2 trials in Phase 3/4
0%
0 of 6 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (13)
Pilot Italian Cardiogenic Shock Initiative
Role: collaborator
PBI for Breast in Situ Carcinoma of Intermediate Low Risk As Local Adjuvant Treatment
Role: collaborator
Imaging and Biological Markers for Prediction and Identification of Glioblastoma Pseudoprogression: a Prospective Study.
Role: collaborator
DTx Algorithms for Personalized Parkinson's Disease Treatment and Medication Plan Optimization
Role: collaborator
Quatitative MRI of the Spinal Cord in Cervical Myelopathy: Assessment of Microstuctural Damage for Outcome Improvement
Role: collaborator
XLIMus Drug Eluting Stent: a randomIzed Controlled Trial to Assess Endothelization
Role: collaborator
Advance Care Planning and Care Coordination for People With Parkinson's Disease
Role: collaborator
Clinical Trial of Abluminus DES+ Sirolimus Eluting Stent Versus Everolimus-eluting DES
Role: collaborator
SALT Study (Switching to the Administration of Lithium Slow -Release Treatment)
Role: collaborator
REspectful CAring for the AGitated Elderly
Role: collaborator
Characterization and Elimination of Mother Rotors
Role: collaborator
Activity of Platelets After Inhibition and Cardiovascular Events Optical Coherence Tomography Study
Role: collaborator
Angiography Versus (vs) IVUS Optimisation
Role: collaborator
All 13 trials loaded